Have a personal or library account? Click to login
The initial results of MRI-TRUS fusion prostate biopsy in high volume tertiary center Cover

The initial results of MRI-TRUS fusion prostate biopsy in high volume tertiary center

Open Access
|Nov 2024

Figures & Tables

FIGURE 1.

Gleason score of all positive biopsy (BX) lesions. Category »not defined« includes lesions with suspect cores for carcinoma, undefined Gleason score in invasive carcinoma and atypical small acinar proliferation (ASAP).
Gleason score of all positive biopsy (BX) lesions. Category »not defined« includes lesions with suspect cores for carcinoma, undefined Gleason score in invasive carcinoma and atypical small acinar proliferation (ASAP).

FIGURE 2.

Gleason score of Prostate Imaging-Reporting and Data System (PIRADS) 3 positive biopsy (BX) lesions.
Gleason score of Prostate Imaging-Reporting and Data System (PIRADS) 3 positive biopsy (BX) lesions.

Comparison of time-based patient groups for learning curve estimation on institution level

Targeted BXSystematic BXOverall BX
Pearson χ2dfsigPearson χ2dfsigPearson χ2dfsig
2 patient groups0.45810.4980.65810.4170.29110.590
3 patient groups2.14520.3422.26520.3221.37320.503
6 patient groups4.80750.4402.87250.7202.32250.803

Patient and lesion characteristics

minmaxmean ± SDmedian
Age (years)359169.0 ± 7.970.0
*Total PSA concentration (ng/mL)0.45115.49.7 ± 11.77.0
Prostate volume (ml)1531352.8 ± 32.345
No. lesions biopsied in a patient131.4 ± 0.61.0
Largest diameter of lesion (mm)3.041.012.8 ± 6.611.5
No. of cores per lesion targeted BX184.26 ± 1.24.0
No. of cores systematic BX0146.9 ± 1.86.0
No. of MRI-TRUS fusion targeted BX performed by urologist before16522.5 ± 19.720.0

Proportion of positive targeted biopsy (BX) lesions categorised by Prostate Imaging-Reporting and Data System (PIRADS) score

Negative BXPositive BXTotal
PIRADS 3 (%)104 (81.9%)23 (18.1%)127
PIRADS 4 (%)108 (52.9%)96 (47.1%)204
PIRADS 5 (%)13 (16.0%)68 (84.0%)81

Results of multiple logistic regression of positive histopathologic result

SigOdds ratio95% C.I. for odds ratio
LowerUpper
Max lesion diameter0.9450.9980.9551.044
Prostate volume< 0.0010.9780.9680.988
*Total PSA concentration0.0501.0501.0001.103
PIRADS 3< 0.001
PIRADS 4< 0.0013.2081.8485.567
PIRADS 5< 0.00116.2226.47540.645
Number of cores per lesion0.0341.2381.0161.508
Number of previous patients with targeted BX performed by urologist0.1131.0130.9971.028
DOI: https://doi.org/10.2478/raon-2024-0060 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 501 - 508
Submitted on: Jun 9, 2024
Accepted on: Oct 9, 2024
Published on: Nov 28, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Tomaz Smrkolj, Milena Taskovska, Iztok Ditz, Klemen Cernelc, Simon Hawlina, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.